CD4 and hepatocellular carcinoma: Studies have pointed out that the expression levels of PLOD1-3 in hepatocellular carcinoma are positively correlated with the activity of infiltrating immune cells, including macrophages, neutrophils, CD4+ T cells, and dendritic cells (Yang et al., 2020).